NEXON Co., Ltd. - NEXOY

NEXOY Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
NEXOY	-0.0	1.8	-2.9	-21.6	-33.6	-12.6	-21.7	-4.6	-9.6	-9.6
S&P 500	1.0	3.7	2.1	2.3	8.2	25.4	31.0	80.6	196.5	33856.2

Compare NEXOY with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	NEXOY
name	NEXON Co., Ltd.
price	13.835
changes percentage	-0.0361
change	-0.005
day low	13.835
day high	13.84
year high	21.74
year low	12.61
market cap	11484283224
price avg 50	14.49046
price avg 200	17.365585
exchange	PNK
volume	100
avg volume	70336
open	13.84
previous close	13.84
eps	0.47
pe	29.44
earnings announcement	2025-02-13T06:00:00.000+0000
shares outstanding	830089138
timestamp	2025-01-17 20:00:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 49.3%

Overall Quarterly Financial Health: 71.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	423356000000	353714000000	19.69
gross profit	285418000000	247936000000	15.12
gross profit ratio	0.67	0.7	-3.82
research and development expenses	24618000000	25930000000	-5.06
operating expenses	147740000000	144240000000	2.43
interest income	40145000000	65323000000	-38.54
interest expense	7279000000	12892000000	-43.54
ebitda	141806000000	115832000000	22.42
ebitdaratio	0.33	0.47	-28.43
operating income	134745000000	158773000000	-15.13
operating income ratio	0.32	0.45	-29.09
net income	70609000000	100339000000	-29.63
net income ratio	0.17	0.28	-41.21
eps	82.33	114.74	-28.25

Overall Score of Annual Income Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 423,356 million in 2023 from 353,714 million in 2022 representing a change of 19.69%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 285,418 million in 2023 from 247,936 million in 2022 representing a change of 15.12%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 141,806 million in 2023 from 115,832 million in 2022 representing a change of 22.42%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Net Income: Net income increased to 70,609 million in 2023 from 100,339 million in 2022 representing a change of -29.63%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 24,618 million in 2023 from 25,930 million in 2022 representing a change of -5.06%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 147,740 million in 2023 from 144,240 million in 2022 representing a change of 2.43%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to 134,745 million in 2023 from 158,773 million in 2022 representing a change of -15.13%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Earnings per Share (EPS): EPS increased to 82.33 in 2023 from 82.33 in 2022 representing a change of -28.25%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
revenue	122474000000	108418000000	12.96
gross profit	78287000000	67861000000	15.36
gross profit ratio	0.64	0.63	2.12
research and development expenses	0	5411000000	-100.00
operating expenses	32422000000	32723000000	-0.92
interest income	19325000000	25680000000	-24.75
interest expense	608000000	518000000	17.37
ebitda	47698000000	31568000000	51.10
ebitdaratio	0.39	0.35	12.42
operating income	45865000000	35138000000	30.53
operating income ratio	0.37	0.32	15.55
net income	39878000000	35918000000	11.03
net income ratio	0.33	0.33	-1.72
eps	47.49	42.77	11.04

Overall Score of Quarterly Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 122,474 million in 2024Q2 from 108,418 million in 2024Q1 representing a change of 12.96%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 78,287 million in 2024Q2 from 67,861 million in 2024Q1 representing a change of 15.36%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 32,422 million in 2024Q2 from 32,723 million in 2024Q1 representing a change of -0.92%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 47,698 million in 2024Q2 from 31,568 million in 2024Q1 representing a change of 51.1%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 45,865 million in 2024Q2 from 35,138 million in 2024Q1 representing a change of 30.53%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 39,878 million in 2024Q2 from 35,918 million in 2024Q1 representing a change of 11.03%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 47.49 in 2024Q2 from 47.49 in 2024Q1 representing a change of 11.04%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2024Q2 from 5,411 million in 2024Q1 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	1098103000000	1042849000000	5.30
total liabilities	191528000000	175303000000	9.26
total equity	906575000000	867546000000	4.50
cash and cash equivalents	280515000000	409368000000	-31.48
short term investments	41582000000	23078000000	80.18
long term investments	238073000000	223031000000	6.74
total current assets	689506000000	642029000000	7.39
total non current assets	408597000000	400820000000	1.94
total current liabilities	89374000000	83134000000	7.51
total non current liabilities	102154000000	92169000000	10.83
common stock	47510000000	38972000000	21.91
retained earnings	707227000000	703342000000	0.55
total debt	29724000000	23324000000	27.44

Overall Score of Annual Balance Sheet

0.6 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,098,103 million in 2023 from 1,042,849 million in 2022 representing a change of 5.3%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 906,575 million in 2023 from 867,546 million in 2022 representing a change of 4.5%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 41,582 million in 2023 from 23,078 million in 2022 representing a change of 80.18%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 689,506 million in 2023 from 642,029 million in 2022 representing a change of 7.39%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 47,510 in 2023 from 38,972 in 2022 representing a change of 21.91%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 707,227 million in 2023 from 703,342 million in 2022 representing a change of 0.55%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 191,528 million in 2023 from 175,303 million in 2022 representing a change of 9.26%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 280,515 million in 2023 from 409,368 million in 2022 representing a change of -31.48%. This indicates a decrease in available liquid assets.

  Total Current Liabilities: Total Current Liabilities increased to 89,374 million in 2023 from 83,134 million in 2022 representing a change of 7.51%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 29,724 million in 2023 from 23,324 million in 2022 representing a change of 27.44%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
total assets	1251699000000	1177945000000	6.26
total liabilities	223737000000	213191000000	4.95
total equity	1027962000000	964754000000	6.55
cash and cash equivalents	230022000000	244227000000	-5.82
short term investments	53970000000	355093000000	-84.80
long term investments	248615000000	272663000000	-8.82
total current assets	760548000000	721317000000	5.44
total non current assets	491151000000	456628000000	7.56
total current liabilities	100003000000	97311000000	2.77
total non current liabilities	123734000000	115880000000	6.78
common stock	49132000000	48228000000	1.87
retained earnings	727354000000	687473000000	5.80
total debt	41592000000	38779000000	7.25

Overall Score of Quarterly Balance Sheet

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,251,699 million in 2024Q2 from 1,177,945 million in 2024Q1 representing a change of 6.26%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 1,027,962 million in 2024Q2 from 964,754 million in 2024Q1 representing a change of 6.55%. This indicates an increase in shareholders' equity.

  Total Current Assets: Total Current Assets increased to 760,548 million in 2024Q2 from 721,317 million in 2024Q1 representing a change of 5.44%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 49,132 in 2024Q2 from 48,228 in 2024Q1 representing a change of 1.87%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 727,354 million in 2024Q2 from 687,473 million in 2024Q1 representing a change of 5.8%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 223,737 million in 2024Q2 from 213,191 million in 2024Q1 representing a change of 4.95%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 230,022 million in 2024Q2 from 244,227 million in 2024Q1 representing a change of -5.82%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 53,970 million in 2024Q2 from 355,093 million in 2024Q1 representing a change of -84.8%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 100,003 million in 2024Q2 from 97,311 million in 2024Q1 representing a change of 2.77%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 41,592 million in 2024Q2 from 38,779 million in 2024Q1 representing a change of 7.25%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-128853000000	44129000000	-391.99
operating cash flow	128712000000	130144000000	-1.10
free cash flow	122999000000	124242000000	-1.00
capital expenditure	-5713000000	-5902000000	3.20
depreciation and amortization	8598000000	6767000000	27.06
deferred income tax	0	0	NaN
stock based compensation	4388000000	9691000000	-54.72
accounts payables	946000000	4089000000	-76.86
inventory	0	-1212000000	100.00
acquisitions net	-26627000000	-19438000000	-36.98
investments in property plant and equipment	-3407000000	-5902000000	42.27
net cash used for investing activites	-188367000000	-10918000000	-1625.29
debt repayment	0	0	NaN
common stock issued	0	6023000000	-100.00
common stock repurchased	-79023000000	-98824000000	20.04
dividends paid	-8579000000	-8785000000	2.34
net cash used provided by financing activities	-78554000000	-105859000000	25.79
cash at end of period	280515000000	409368000000	-31.48
accounts receivables	-4516000000	-8968000000	49.64
cash at beginning of period	409368000000	365239000000	12.08

Overall Score of Annual Cashflow Statement

0.38 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -128,853 million in 2023 from 44,129 million in 2022 representing a change of -391.99%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 128,712 million in 2023 from 130,144 million in 2022 representing a change of -1.1%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 122,999 million in 2023 from 124,242 million in 2022 representing a change of -1.0%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -5,713 million in 2023 from -5,902 million in 2022 representing a change of 3.2%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Receivables: Accounts Receivables increased to -4,516 in 2023 from -8,968 million in 2022 representing a change of 49.64%. This suggests that the company is less capable of collecting payments from its customers.

• 📈 Positive Indicators

  Stock-Based Compensation: Stock-Based Compensation decreased to 4,388 million in 2023 from 9,691 million in 2022 representing a change of -54.72%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 946 million in 2023 from 4,089 million in 2022 representing a change of -76.86%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid increased to -8,579 million in 2023 from -8,785 million in 2022 representing a change of 2.34%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
operating cash flow	22126000000	12183000000	81.61
free cash flow	20651000000	10480000000	97.05
capital expenditure	-1475000000	-1703000000	13.39
depreciation and amortization	2474000000	2422000000	2.15
deferred income tax	0	0	NaN
stock based compensation	923000000	797000000	15.81
accounts receivables	-21585000000	-20133000000	-7.21
accounts payables	821000000	1831000000	-55.16
inventory	0	0	NaN
acquisitions net	-4000000	1795000000	-100.22
investments in property plant and equipment	-992000000	-1703000000	41.75
net cash used for investing activites	-22551000000	-45293000000	50.21
debt repayment	0	0	NaN
common stock issued	1236000000	1033000000	19.65
common stock repurchased	-20580000000	-7759000000	-165.24
dividends paid	-105000000	-4109000000	97.44
net cash used provided by financing activities	-20540000000	-11881000000	-72.88
net change in cash	-14205000000	-36288000000	60.85
cash at end of period	230022000000	244227000000	-5.82
cash at beginning of period	244227000000	280515000000	-12.94

Overall Score of Quarterly Cashflow Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -14,205 million in 2024Q2 from -36,288 million in 2024Q1 representing a change of 60.85%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 22,126 million in 2024Q2 from 12,183 million in 2024Q1 representing a change of 81.61%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 20,651 million in 2024Q2 from 10,480 million in 2024Q1 representing a change of 97.05%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables decreased to 821 million in 2024Q2 from 1,831 million in 2024Q1 representing a change of -55.16%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -21,585 million in 2024Q2 from -20,133 million in 2024Q1 representing a change of -7.21%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -105 million in 2024Q2 from -4,109 million in 2024Q1 representing a change of 97.44%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -1,475 million in 2024Q2 from -1,703 million in 2024Q1 representing a change of 13.39%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Stock-Based Compensation: Stock-Based Compensation increased to 923 million in 2024Q2 from 797 million in 2024Q1 representing a change of 15.81%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript
Q3 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	496.99	404.47	22.87
net income per share	82.89	114.74	-27.76
operating cash flow per share	151.1	148.82	1.53
free cash flow per share	144.39	142.07	1.63
cash per share	700.55	494.5	41.67
book value per share	1064.25	992.03	7.28
tangible book value per share	991.74	935.09	6.06
shareholders equity per share	1052.15	981.33	7.22
interest debt per share	43.44	41.41	4.89
market cap	2188806045624	2590317721938	-15.50
enterprise value	1938015045624	2204273721938	-12.08
pe ratio	31.0	25.82	20.08
price to sales ratio	5.17	7.32	-29.40
pocfratio	17.01	19.9	-14.56
pfcf ratio	17.8	20.85	-14.65
pb ratio	2.44	3.02	-19.09
ptb ratio	2.44	3.02	-19.09
ev to sales	4.58	6.23	-26.54
enterprise value over ebitda	13.67	19.03	-28.18
ev to operating cash flow	15.06	16.94	-11.10
ev to free cash flow	15.76	17.74	-11.19
earnings yield	0.03	0.04	-16.72
free cash flow yield	0.06	0.05	17.16
debt to equity	0.03	0.03	22.03
debt to assets	0.03	0.02	21.03
net debt to ebitda	-1.77	-3.33	46.93
current ratio	7.71	7.72	-0.10
interest coverage	18.91	12.32	53.58
income quality	1.82	0.93	96.83
dividend yield	0.0	0.0	15.57
payout ratio	0.12	0.09	38.77
sales general and administrative to revenue	0.35	0.39	-11.39
research and ddevelopement to revenue	0.06	0.07	-20.68
intangibles to total assets	0.06	0.05	17.82
capex to operating cash flow	0.04	0.05	-2.13
capex to revenue	0.01	0.02	-19.13
capex to depreciation	0.66	0.87	-23.82
stock based compensation to revenue	0.01	0.03	-62.17
graham number	1400.82	1591.66	-11.99
roic	0.08	0.12	-35.75
return on tangible assets	0.07	0.1	-32.57
graham net net	509.06	413.05	23.24
working capital	600132000000	558895000000	7.38
tangible asset value	844804000000	817755000000	3.31
net current asset value	497978000000	466726000000	6.70
invested capital	714757000000	654650000000	9.18
average receivables	34158500000	24010500000	42.26
average payables	15518500000	12029500000	29.00
average inventory	81245000000	166089500000	-51.08
days sales outstanding	32.65	31.42	3.94
days payables outstanding	41.91	50.74	-17.41
days of inventory on hand	0	560.69	-100.00
receivables turnover	11.18	11.62	-3.79
payables turnover	8.71	7.19	21.08
inventory turnover	0	0.65	-100.00
roe	0.08	0.12	-32.62
capex per share	6.71	6.75	-0.63

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 31.00 on 2023-12-31 from 25.82 on 2022-12-31, representing a change of 20.08%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.03 on 2023-12-31 from 0.03 on 2022-12-31, representing a change of 22.03%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Negative

  Current Ratio: Current Ratio decreased to 7.71 on 2023-12-31 from 7.72 on 2022-12-31, representing a change of -0.10%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Quarterly Financial Ratios

	2024-06-30 Q2	2024-03-31 Q1	Q/Q change %
NEXOY
calendar year	2024	2024	NaN
revenue per share	146.39	129.1	13.39
net income per share	47.67	42.77	11.45
operating cash flow per share	26.45	14.51	82.30
free cash flow per share	24.68	12.48	97.80
cash per share	725.87	713.64	1.71
book value per share	1228.7	1148.78	6.96
tangible book value per share	1141.45	1064.93	7.19
shareholders equity per share	1216.17	1136.18	7.04
interest debt per share	50.44	46.79	7.80
market cap	2453826111100	2116309235040	15.95
enterprise value	2265396111100	1910861235040	18.55
pe ratio	15.38	14.73	4.43
price to sales ratio	20.04	19.52	2.64
pocfratio	110.9	173.71	-36.16
pfcf ratio	118.82	201.94	-41.16
pb ratio	2.41	2.22	8.73
ptb ratio	2.41	2.22	8.73
ev to sales	18.5	17.62	4.95
enterprise value over ebitda	33.8	60.53	-44.16
ev to operating cash flow	102.39	156.85	-34.72
ev to free cash flow	109.7	182.33	-39.84
earnings yield	0.02	0.02	-4.25
free cash flow yield	0.01	0.0	69.95
debt to equity	0.04	0.04	0.58
debt to assets	0.03	0.03	0.93
net debt to ebitda	-2.81	-6.51	56.80
current ratio	7.61	7.41	2.60
interest coverage	75.44	67.83	11.21
income quality	0.55	0.34	63.58
dividend yield	0.0	0.0	-97.80
payout ratio	0.0	0.11	-97.70
sales general and administrative to revenue	0.26	0.3	-12.29
research and ddevelopement to revenue	0	0.05	-100.00
intangibles to total assets	0.06	0.06	-2.46
capex to operating cash flow	0.07	0.14	-52.31
capex to revenue	0.01	0.02	-23.33
capex to depreciation	0.6	0.7	-15.21
stock based compensation to revenue	0.01	0.01	2.52
graham number	1142.06	1045.64	9.22
roic	0.03	0.02	17.63
return on tangible assets	0.03	0.03	4.32
graham net net	533.15	512.34	4.06
working capital	660545000000	624006000000	5.86
tangible asset value	954971000000	894333000000	6.78
net current asset value	536811000000	508126000000	5.65
invested capital	800730000000	757762000000	5.67
average receivables	71090500000	48359000000	47.01
average payables	19265000000	17448000000	10.41
average inventory	0	0	NaN
days sales outstanding	61.24	48.85	25.37
days payables outstanding	40.67	41.2	-1.28
days of inventory on hand	0	0	NaN
receivables turnover	1.47	1.84	-20.23
payables turnover	2.21	2.18	1.30
inventory turnover	0	0	NaN
roe	0.04	0.04	4.12
capex per share	1.76	2.03	-13.06

• Negative

  ROE: Return on Equity (ROE) decreased to 0.04 on 2024-06-30 Q2 from 0.04 on 2024-03-31 Q1, representing a change of 4.12%. Suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio increased to 7.61 on 2024-06-30 Q2 from 7.41 on 2024-03-31 Q1, representing a change of 2.60%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 15.38 on 2024-06-30 Q2 from 14.73 on 2024-03-31 Q1, representing a change of 4.43%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.04 on 2024-06-30 Q2 from 0.04 on 2024-03-31 Q1, representing a change of 0.58%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None